• Activity INFORMATION

  Overview

  Approximately 50 million people were affected by dementias in 2018, and this number is expected to double every 20 years. There is, unfortunately, no cure for dementia, and treatment to limit progression is limited. Healthcare providers must be comfortable with discussing implications of dementia, as well as the nuances with available therapy. Recently in 2021, a novel therapy was approved with significant discussions on its implications.
  

  Handouts

  • Slide Document :   21286H01_2pp.pdf Download

  • Slide Document :   21286H01_6pp.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Assess novel and emerging therapy for dementia

  Select an appropriate therapy based on clinical pearls and updated literature for dementia care

  Identify available pharmacotherapy for the treatment of dementia

  Pharmacy Technician

  Identify FDA-approved therapies and review the doses, common side effects, and drug interactions

  Identify the signs and symptoms of various types of dementia

  Recognize novel and emerging therapy for dementia

  Nurse

  Assess novel and emerging therapy for dementia

  Identify available pharmacotherapy for the treatment of dementia

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-895796

  Universal Activity Number

  Pharmacist 0798-0000-21-286-H01-P
  Pharmacy Technician 0798-0000-21-286-H01-T
  Nurse 0798-0000-21-286-H01-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Megan  Adelman, PharmD, BCPS, BCGP, CDE Family Medicine Pharmacy Specialist, Cleveland Clinic Akron General

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).